Which factors affect treatment selection in hemodynamically stable ventricular tachycardia (VT)?

Updated: Dec 05, 2017
  • Author: Steven J Compton, MD, FACC, FACP, FHRS; Chief Editor: Jeffrey N Rottman, MD  more...
  • Print
Answer

Stable patients have adequate vital end-organ perfusion and thus do not experience signs or symptoms of hemodynamic compromise. Treatment depends on whether the VT is monomorphic or polymorphic and whether left ventricular (LV) function is normal or impaired (eg, reduced LV ejection fraction [LVEF], heart failure).


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!